eISSN: 1643-3750

Logo



Get your full text copy in PDF

A novel vitamin C preparation enhances neurite formation and fibroblast adhesion and reduces xenobiotic-induced T-cell hyperactivation

Benjamin S. Weeks, Pedro P. Perez

Med Sci Monit 2007; 13(3): BR51-58

ID: 475504


Background: Vitamin C (ascorbic acid, ascorbate) has been shown to enhance neurite outgrowth, promote fi broblast adhesion during wound healing, and reduce xenobiotic-induced leukocyte hyperactivity and
infl ammatory damage. In this study, a comparison was made between Ester-C® and PureWay-C™ on these various cellular activities.
Material/Methods: PC12 cells were stimulated to form neurites with nerve growth factor, NIH 3T3 fi broblasts were seeded on fi bronectin and H9 T-cells were stimulated to aggregate with the pyrethroid pesticide
bifenthrin. The rate of neurite formation, fi broblast adhesion and T-cell homotypic aggregation was then measured in the absence and presence of various formulations of vitamin C including Ester-C® and PureWay-C™.
Results: With PureWay-C™ treatment, 12% of PC12 cells extended neurites within one hour of treatment and 45% of the cells extended neurites by hour nine. With Ester-C®, 0% and 15% extended neurites at one and nine hours, respectively. NIH-3T3 fi broblast adhesion to fi bronectin was enhanced
by 4.7-fold with a 30 minute PureWay-C™ treatment while Ester-C® increased fi broblast adhesion by only 1.5 fold. Further, PureWay-C™ reduced pesticide-mediated T-cell homotypic aggregation
by 83% within 30 minutes of treatment while the reduction seen with Ester-C® was only 33%.
Conclusions: These data confi rm the previous observations that vitamin C supplementation can promote neurite outgrowth, increase fi broblast adhesion and reduce xenobiotic induce immunocytes aggregation.
More importantly, these data show that PureWay-C™ has a faster and greater benefi cial effect on these parameters when compared to other vitamin C formulations.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree